Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection.
J Viral Hepat
; 25(10): 1180-1188, 2018 10.
Article
in En
| MEDLINE
| ID: mdl-29660224
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Hepatitis C
/
Hepacivirus
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Country/Region as subject:
Europa
/
Oceania
Language:
En
Journal:
J Viral Hepat
Journal subject:
GASTROENTEROLOGIA
Year:
2018
Document type:
Article
Affiliation country:
Australia
Country of publication:
Reino Unido